View Press Releases
-
Alfa Chemistry Released Ion Sensor Materials for Analytical and Chromatography Applications
-
Dotmatics announces licensing agreement for informatics software with Compugen
Compugen selects Dotmatics’ cloud-based LIMS and ELN solution to drive efficient drug discovery Agreement marks the first implementation of Dotmatics SaaS technology in Israel, further extending global access
Mar 2, 2021
-
IDT Launches rhAmpSeq™ CRISPR Analysis System
Integrated DNA Technologies (IDT) has launched its rhAmpSeq™ CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.
Mar 2, 2021
-
AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management
AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.
Mar 7, 2021
-
CARLSBAD, Calif. – Thermo Fisher Scientific Launches 3,000 L and 5,000 L HyPerforma DynaDrive Single-Use Bioreactors (S.U.B.s) for Cell Culture Production
-
Further European expansion for G&L Scientific
Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.
Mar 8, 2021
-
SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines
SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.
Mar 9, 2021
-
Northeast Georgia Health System Elevates Its Digital Consumer Experience with Self-Service Capabilities from Kyruus
-
VERICHEM LABORATORIES ANNOUNCES EXTENDED STABILITY CLAIMS FOR ITS AMMONIA/IRON CLINICAL REFERENCE STANDARD
VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
Mar 7, 2021
-
Standigm Secures $44.5 M in Pre-IPO Funding Round
Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
Mar 4, 2021
-
Evolving Risks, Insecure Defaults, Watering Hole Threats: New Research from Accurics Uncovers Developing Sources of Cloud Risk
-
Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation
A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
Feb 17, 2021
-
Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth
-
Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO
-
Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.
• Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse. • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
Jan 25, 2021
-
Europital board forewarns that clinical deficits to slow biotech development in 2021
-
Ashfield Engage launches with an integrated offering to maximize engagement with patients, HCPs and payers
-
John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand
John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
Feb 1, 2021
-
SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant
SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Feb 14, 2021
-
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence